PDE4A Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of PDE4A monoclonal antibodies for research focused on understanding phosphodiesterase 4A protein. PDE4A monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). PDE4A is a key enzyme involved in the hydrolysis of cyclic AMP, a critical second messenger in numerous signaling pathways. By regulating cyclic AMP levels, PDE4A plays a significant role in various physiological processes, including inflammation, immune response, and neuronal signaling. Understanding PDE4A function is essential for developing therapeutic strategies for diseases such as asthma, chronic obstructive pulmonary disease (COPD), and depression. Researchers worldwide rely on PDE4A monoclonal antibodies to advance their studies in cellular signaling pathways. PDE4A research continues to reveal new insights into disease mechanisms and potential therapeutic targets. The specificity and reliability of Santa Cruz Biotechnology monoclonal antibodies enable researchers to make meaningful contributions to scientific understanding of PDE4A's role in health and disease.